Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionmonoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential

SLC8A1 SLC8A3

2.48e-0521002GO:0099580
GeneOntologyMolecularFunctionarylamine N-acetyltransferase activity

NAT1 NAT2

7.42e-0531002GO:0004060
GeneOntologyMolecularFunctioncalcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration

SLC8A1 SLC8A3

7.42e-0531002GO:1905060
GeneOntologyMolecularFunctionphosphorylase kinase activity

PHKG1 PHKG2

1.48e-0441002GO:0004689
DomainArylamine_N-AcTrfase

NAT1 NAT2

2.78e-052992IPR001447
DomainAcetyltransf_2

NAT1 NAT2

2.78e-052992PF00797
DomainPhosph_kin_gamma

PHKG1 PHKG2

2.78e-052992IPR002291
DomainNa_Ca_Ex

SLC8A1 SLC8A3

8.32e-053992IPR004836
DomainNa_Ca_Ex_C-exten

SLC8A1 SLC8A3

8.32e-053992IPR032452
DomainNa_Ca_ex_C

SLC8A1 SLC8A3

8.32e-053992PF16494
DomainDUF21

CNNM2 CNNM3

1.66e-044992IPR002550
DomainDUF21

CNNM2 CNNM3

1.66e-044992PF01595
DomaincAMP_dep_PK_reg_su

PRKAR1A PRKAR1B

1.66e-044992IPR012198
DomainG_patch

GPATCH1 GPATCH11 SON

2.37e-0423993SM00443
DomainG_patch_dom

GPATCH1 GPATCH11 SON

2.37e-0423993IPR000467
DomainG_PATCH

GPATCH1 GPATCH11 SON

2.37e-0423993PS50174
DomainG-patch

GPATCH1 GPATCH11 SON

2.37e-0423993PF01585
DomainSMC

SMC1A SMC1B

2.75e-045992IPR024704
DomainSMC_hinge

SMC1A SMC1B

4.11e-046992PF06470
DomainSMC_hinge

SMC1A SMC1B

4.11e-046992SM00968
DomainSMC_hinge

SMC1A SMC1B

4.11e-046992IPR010935
DomainRIIa

PRKAR1A PRKAR1B

4.11e-046992SM00394
DomainRIIa

PRKAR1A PRKAR1B

5.74e-047992PF02197
DomainCalx_beta

SLC8A1 SLC8A3

7.63e-048992SM00237
DomainRecF/RecN/SMC_N

SMC1A SMC1B

7.63e-048992IPR003395
DomainSMC_N

SMC1A SMC1B

7.63e-048992PF02463
DomainCalx_beta

SLC8A1 SLC8A3

9.77e-049992IPR003644
DomainNaCa_Exmemb

SLC8A1 SLC8A3

9.77e-049992IPR004837
DomainNa_Ca_ex

SLC8A1 SLC8A3

9.77e-049992PF01699
DomainCalx-beta

SLC8A1 SLC8A3

9.77e-049992PF03160
DomainELM2

MTA3 ZNF541

2.09e-0313992PF01448
DomainELM2

MTA3 ZNF541

2.09e-0313992PS51156
DomainELM2_dom

MTA3 ZNF541

2.09e-0313992IPR000949
DomainELM2

MTA3 ZNF541

2.09e-0313992SM01189
Domain-

CNNM2 PRKAR1A PRKAR1B

2.10e-03489932.60.120.10
DomainRmlC-like_jellyroll

CNNM2 PRKAR1A PRKAR1B

2.50e-0351993IPR014710
DomainDnaJ_domain

DNAJB8 SLC8A1 DNAJC9

2.50e-0351993IPR001623
DomaincAMP_dep_PK_reg_su_I/II_a/b

PRKAR1A PRKAR1B

2.79e-0315992IPR003117
DomaincNMP-bd_CS

PRKAR1A PRKAR1B

3.18e-0316992IPR018488
DomainPBD

CDC42BPA WAS

3.18e-0316992SM00285
DomainDH_1

ARHGEF38 ARHGEF12 VAV3

4.56e-0363993PS00741
Domain-

CDC42BPA WAS DOCK11 IQSEC2 ARHGEF12 EPB41L5 VAV3

4.78e-033919972.30.29.30
DomainCBS_dom

CNNM2 CNNM3

4.97e-0320992IPR000644
DomainCBS

CNNM2 CNNM3

4.97e-0320992PF00571
DomainCBS

CNNM2 CNNM3

4.97e-0320992PS51371
DomainCRIB

CDC42BPA WAS

4.97e-0320992PS50108
DomainCRIB_dom

CDC42BPA WAS

5.47e-0321992IPR000095
DomainRhoGEF

ARHGEF38 ARHGEF12 VAV3

5.64e-0368993SM00325
DomainRhoGEF

ARHGEF38 ARHGEF12 VAV3

6.12e-0370993PF00621
DomainDH_2

ARHGEF38 ARHGEF12 VAV3

6.12e-0370993PS50010
DomainDH-domain

ARHGEF38 ARHGEF12 VAV3

6.36e-0371993IPR000219
Domain-

ARHGEF38 ARHGEF12 VAV3

6.36e-03719931.20.900.10
PathwayBIOCARTA_AGPCR_PATHWAY

GRK4 PRKAR1A PRKAR1B

1.90e-0510783MM1352
PathwayBIOCARTA_AGPCR_PATHWAY

GRK4 PRKAR1A PRKAR1B

2.60e-0511783M19829
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

HSPD1 PMS1 DLG5 CDC42BPA SYNE1 PSMA7 EPB41L5 NCL UNC45A DNAJB8 CNNM3 KIDINS220 WDR11 LNPEP MRPS23 DNAJC9 PRKAR1A PRKAR1B TMPO CUX1 NIN

1.83e-0914871022133957083
Pubmed

A human MAP kinase interactome.

HSPD1 CDC42BPA WAS SYNE1 NCL POM121C CEP350 PRKAR1A PRKAR1B VAV3 KIF5B CUX1

2.10e-084861021220936779
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

TPM3 DLG5 ATP6V1C1 PRSS8 CDC42BPA COX16 SYNE1 ARHGEF12 EPB41L5 URB2 UNC45A KIDINS220 MTA3 WDR11 LNPEP MRPS23 DNAJC9 PRKAR1A SON

6.57e-0814971021931527615
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

HSPD1 USP34 CDC42BPA GPATCH1 INSR EPB41L5 MAGEC3 NCL CEP350 CNNM3 KIDINS220 WDR11 TMPO CUX1

6.66e-087771021435844135
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

HSPD1 DLG5 CDC42BPA SMC1A ARHGEF12 EPB41L5 UNC45A KIDINS220 RUVBL1 HSD17B12 TMPO KIF5B KPNA2

1.64e-077081021339231216
Pubmed

Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease.

NAT1 NAT2 INSR

2.44e-075102333296651
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

HSPD1 TPM3 SYNE1 SMC1A INSR NCL URB2 CEP350 CNNM3 RUVBL1 PRKAR1A TMPO KIF5B SON KPNA2

3.13e-0710241021524711643
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

HSPD1 TPM3 SYNE1 SMC1A PSMA7 NCL URB2 UNC45A KIDINS220 RUVBL1 DNAJC9 PRKAR1A HSD17B12 TMPO KIF5B GALNT5 KPNA2

8.35e-0714251021730948266
Pubmed

Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.

HSPD1 PSMA7 NCL UNC45A RUVBL1 PRKAR1A HSD17B12 KIF5B KPNA2

1.77e-06377102925147182
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

PMS1 SMC1A RSF1 ZEB2 FSIP2 MTA3 GPATCH11 DNAJC9 TMPO CUX1 KPNA2

1.80e-066081021136089195
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

TPM3 CDC42BPA DOCK11 SMC1A PSMA7 ARHGEF12 UNC45A RUVBL1 MTMR14 MRPS23 DNAJC9 VAV3 KPNA2

2.91e-069161021332203420
Pubmed

A COFRADIC protocol to study protein ubiquitination.

PMS1 PSMA7 NCL RUVBL1 PRKAR1A HSD17B12

2.91e-06134102624816145
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

HSPD1 DLG5 CDC42BPA SYNE1 SMC1A NCL KIDINS220 RUVBL1 MAMDC2 MRPS23 HSD17B12 TMPO SON KPNA2

3.42e-0610821021438697112
Pubmed

Transcription factor protein interactomes reveal genetic determinants in heart disease.

HSPD1 CDC42BPA SMC1A RSF1 RUVBL1 MTA3 TMPO SON KPNA2

3.58e-06411102935182466
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

HSPD1 TPM3 PMS1 GPATCH1 RSF1 NCL UNC45A POM121C LZIC RUVBL1 TMPO KIF5B SON

3.59e-069341021333916271
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

HSPD1 TPM3 DLG5 SMC1A NCL UNC45A RUVBL1 MTA3 WDR11 MRPS23 DNAJC9 HSD17B12 TMPO KIF5B KPNA2

3.96e-0612571021536526897
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

HSPD1 TPM3 DLG5 SYNE1 SMC1A EPB41L5 NCL UNC45A DNAJC9 KIF5B GFPT2 SON KPNA2

4.27e-069491021336574265
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

HSPD1 TPM3 USP34 ATP6V1C1 SMC1A PSMA7 NCL ARMC9 UNC45A RUVBL1 MTA3 LNPEP PRKAR1A PRKAR1B KIF5B KPNA2

5.16e-0614551021622863883
Pubmed

Network organization of the human autophagy system.

SMC1A UNC45A ATG4B WDR11 XIRP2 PRKAR1A HSD17B12 TMPO KIF5B

5.87e-06437102920562859
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

HSPD1 TPM3 SMC1A PSMA7 NCL UNC45A PHKG2 RUVBL1 MRPS23 DNAJC9 PRKAR1A TMPO KIF5B KPNA2

6.78e-0611491021435446349
Pubmed

Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.

HSPD1 CNNM2 SYNE1 CEP350 CNNM3 PHKG2 RUVBL1 HSD17B12 CUX1 KPNA2

7.47e-065731021028330616
Pubmed

Systematic and quantitative assessment of the ubiquitin-modified proteome.

PMS1 PSMA7 NCL RUVBL1 PRKAR1A HSD17B12

7.51e-06158102621906983
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

HSPD1 TPM3 DLG5 IFFO1 GPATCH1 UNC45A CEP350 RUVBL1 MTMR14 WDR11 KIF5B NIN

7.86e-068531021228718761
Pubmed

RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.

HSPD1 CDC42BPA NCL RUVBL1 MRPS23 HSD17B12 TMPO KPNA2

8.26e-06344102836282215
Pubmed

Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?

NAT1 NAT2

8.52e-062102215770721
Pubmed

Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.

NAT1 NAT2

8.52e-062102219549810
Pubmed

Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.

NAT1 NAT2

8.52e-062102216098511
Pubmed

Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.

NAT1 NAT2

8.52e-06210229070359
Pubmed

Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.

NAT1 NAT2

8.52e-062102223168701
Pubmed

Association of NAT1 and NAT2 genes with nonsyndromic cleft lip and palate.

NAT1 NAT2

8.52e-062102223660777
Pubmed

NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.

SLC8A1 SLC8A3

8.52e-062102229941946
Pubmed

SMC1α Substitutes for Many Meiotic Functions of SMC1β but Cannot Protect Telomeres from Damage.

SMC1A SMC1B

8.52e-062102229337080
Pubmed

Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases.

NAT1 NAT2

8.52e-062102217656365
Pubmed

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

NAT1 NAT2

8.52e-062102212135032
Pubmed

Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver.

NAT1 NAT2

8.52e-062102228888949
Pubmed

Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism.

NAT1 NAT2

8.52e-062102220026257
Pubmed

N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus.

NAT1 NAT2

8.52e-062102214705222
Pubmed

Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.

NAT1 NAT2

8.52e-062102217522066
Pubmed

[The biological role of prokaryotic and eukaryotic N-acetyltransferase].

NAT1 NAT2

8.52e-062102223420430
Pubmed

Promoter for the regulatory type I beta subunit of the 3',5'-cyclic adenosine monophosphate-dependent protein kinase directs transgene expression in the central nervous system.

PRKAR1A PRKAR1B

8.52e-06210221448119
Pubmed

A readout of metabolic efficiency in arylamine N-acetyltransferase-deficient mice reveals minor energy metabolism changes.

NAT1 NAT2

8.52e-062102230883722
Pubmed

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.

NAT1 NAT2

8.52e-062102212682333
Pubmed

Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2.

NAT1 NAT2

8.52e-06210221559981
Pubmed

Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.

NAT1 NAT2

8.52e-062102229214875
Pubmed

Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms.

NAT1 NAT2

8.52e-062102215127906
Pubmed

Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.

NAT1 NAT2

8.52e-062102217675654
Pubmed

N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.

NAT1 NAT2

8.52e-062102226409796
Pubmed

Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.

NAT1 NAT2

8.52e-062102225413361
Pubmed

Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.

NAT1 NAT2

8.52e-062102216847422
Pubmed

Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1.

NAT1 NAT2

8.52e-062102210640510
Pubmed

Effects of microRNA-217 on proliferation, apoptosis, and autophagy of hepatocytes in rat models of CCL4-induced liver injury by targeting NAT2.

NAT1 NAT2

8.52e-062102230417525
Pubmed

The organization of the human gene NCX1 encoding the sodium-calcium exchanger.

SLC8A1 SLC8A3

8.52e-06210228921376
Pubmed

Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.

NAT1 NAT2

8.52e-062102211266080
Pubmed

N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.

NAT1 NAT2

8.52e-062102219379125
Pubmed

Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study.

NAT1 NAT2

8.52e-062102220570911
Pubmed

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice.

NAT1 NAT2

8.52e-062102229237750
Pubmed

Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.

NAT1 NAT2

8.52e-062102219663877
Pubmed

Genetic regulation of aromatic amine N-acetylation in inbred mice.

NAT1 NAT2

8.52e-06210226976963
Pubmed

Nomenclature for N-acetyltransferases.

NAT1 NAT2

8.52e-06210227773298
Pubmed

NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.

NAT1 NAT2

8.52e-062102225886288
Pubmed

TRAC variants associate with IgA nephropathy.

TRA TRAC

8.52e-062102219470682
Pubmed

Update on consensus arylamine N-acetyltransferase gene nomenclature.

NAT1 NAT2

8.52e-062102210862519
Pubmed

Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.

NAT1 NAT2

8.52e-062102211034589
Pubmed

Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.

NAT1 NAT2

8.52e-062102216981843
Pubmed

Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.

NAT1 NAT2

8.52e-062102222644701
Pubmed

Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.

NAT1 NAT2

8.52e-062102212815173
Pubmed

Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice.

NAT1 NAT2

8.52e-062102212142728
Pubmed

Molecular genetic basis of rapid and slow acetylation in mice.

NAT1 NAT2

8.52e-06210221875909
Pubmed

Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice.

NAT1 NAT2

8.52e-062102222193722
Pubmed

NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant.

NAT1 NAT2

8.52e-062102215142281
Pubmed

5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion.

NAT1 NAT2

8.52e-062102224205029
Pubmed

Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.

NAT1 NAT2

8.52e-062102217961509
Pubmed

Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.

NAT1 NAT2

8.52e-062102218199719
Pubmed

Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.

NAT1 NAT2

8.52e-062102218372103
Pubmed

Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.

NAT1 NAT2

8.52e-062102212037388
Pubmed

Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study.

NAT1 NAT2

8.52e-062102218022202
Pubmed

Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.

NAT1 NAT2

8.52e-062102211431340
Pubmed

Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review.

NAT1 NAT2

8.52e-062102230222709
Pubmed

N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.

NAT1 NAT2

8.52e-062102219898993
Pubmed

Effects of genetic polymorphisms of N-Acetyltransferase on trichloroethylene-induced hypersensitivity dermatitis among exposed workers.

NAT1 NAT2

8.52e-062102219834256
Pubmed

Carcinogen metabolism, cigarette smoking, and breast cancer risk: a Bayes model averaging approach.

NAT1 NAT2

8.52e-062102221080951
Pubmed

IQ-ArfGEF/BRAG1 is associated with synaptic ribbons in the mouse retina.

IQSEC2 ARHGEF12

8.52e-062102219811534
Pubmed

Association of arylamine N-acetyltransferase (NAT1 and NAT2) genotypes with urinary bladder cancer risk.

NAT1 NAT2

8.52e-062102214564055
Pubmed

The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.

PHKG1 PHKG2

8.52e-06210229362479
Pubmed

Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.

NAT1 NAT2

8.52e-062102218006927
Pubmed

Arylamine N-acetyl transferase in mice.

NAT1 NAT2

8.52e-06210221397516
Pubmed

The chromosomal location of T-cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemia.

TRA TRAC

8.52e-06210223875483
Pubmed

Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene.

NAT1 NAT2

8.52e-062102212815365
Pubmed

NAT2 variation and idiopathic talipes equinovarus (clubfoot).

NAT1 NAT2

8.52e-062102217726690
Pubmed

Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.

NAT1 NAT2

8.52e-062102215784508
Pubmed

Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene.

NAT1 NAT2

8.52e-062102225798622
Pubmed

Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2.

NAT1 NAT2

8.52e-062102211060463
Pubmed

RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.

NAT1 NAT2

8.52e-062102221347396
Pubmed

Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers.

SLC8A1 SLC8A3

8.52e-062102221790537
Pubmed

A structural basis for immunodominant human T cell receptor recognition.

TRA TRAC

8.52e-062102212796775
Pubmed

The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity.

CNNM2 CNNM3

8.52e-062102230341174
Pubmed

Nat1 promotes translation of specific proteins that induce differentiation of mouse embryonic stem cells.

NAT1 NAT2

8.52e-062102228003464
Pubmed

Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.

NAT1 NAT2

8.52e-062102211751443
Pubmed

Arylamine N-acetyltransferase 2 expression in the developing heart.

NAT1 NAT2

8.52e-062102215872051
Pubmed

N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.

NAT1 NAT2

8.52e-062102225689677
InteractionRHOQ interactions

DLG5 CDC42BPA WAS DOCK11 EPB41L5 INPP5F CNNM3 KIDINS220 WDR11 LNPEP TMPO

1.35e-0544210111int:RHOQ
InteractionCFAP184 interactions

TPM3 IFFO1 IQSEC2 NUF2 CEP350 PRKAR1B NIN

1.74e-051621017int:CFAP184
InteractionPTPRR interactions

HSPD1 INSR NCL MTMR14 MRPS23 TMPO

1.92e-051101016int:PTPRR
InteractionMARCKS interactions

HSPD1 TPM3 CDC42BPA EPB41L5 CNNM3 KIDINS220 RUVBL1 WDR11 LNPEP PRKAR1B TMPO KPNA2

4.71e-0560110112int:MARCKS
InteractionRHOH interactions

HSPD1 TPM3 DLG5 CDC42BPA EPB41L5 INPP5F CNNM3 KIDINS220 WDR11 LNPEP TMPO

5.17e-0551210111int:RHOH
InteractionSMARCAD1 interactions

ZFP42 SMC1A DNAJB8 RUVBL1 MTA3 DNAJC9 TMPO

6.07e-051971017int:SMARCAD1
InteractionSMC1B interactions

SMC1A RNF17 SMC1B

6.53e-05161013int:SMC1B
InteractionLURAP1 interactions

TPM3 DLG5 CDC42BPA NUF2 EXOC6B GFPT2

6.60e-051371016int:LURAP1
InteractionSOX2 interactions

HSPD1 USP34 DLG5 CDC42BPA SMC1A PSMA7 NCL ZEB2 KIDINS220 RUVBL1 MTA3 MRPS23 DNAJC9 PRKAR1A HSD17B12 TMPO MAGEC2 CUX1 NIN

7.31e-05142210119int:SOX2
InteractionCDCA5 interactions

HSPD1 SMC1A UNC45A RUVBL1 PRKAR1A SMC1B

7.44e-051401016int:CDCA5
InteractionRAC1 interactions

DLG5 CDC42BPA WAS DOCK11 IQSEC2 EPB41L5 NCL CNNM3 PHKG2 KIDINS220 WDR11 LNPEP KRT40 TMPO VAV3 KPNA2

7.47e-05106310116int:RAC1
InteractionCDC5L interactions

HSPD1 PMS1 SYNE1 SMC1A GPATCH1 NCL NUF2 UNC45A RNF17 RUVBL1 TMPO KIF5B SON KPNA2

9.14e-0585510114int:CDC5L
InteractionCDC42 interactions

PMS1 DLG5 CDC42BPA WAS DOCK11 SYNE1 ARHGEF12 EPB41L5 NCL URB2 CNNM3 KIDINS220 RUVBL1 WDR11 LNPEP HSD17B12 TMPO KPNA2

9.27e-05132310118int:CDC42
InteractionZBTB7B interactions

SYNE1 NCL ZEB2 RUVBL1 MTA3 TMPO CUX1 KPNA2 NIN

9.36e-053661019int:ZBTB7B
InteractionGJD3 interactions

DLG5 CDC42BPA SYNE1 INSR EPB41L5 POM121C KIDINS220 LNPEP HSD17B12 TMPO

9.41e-0545410110int:GJD3
GeneFamilyArylamine N-acetyltransferases

NAT1 NAT2

5.50e-0537821133
GeneFamilyG-patch domain containing|Minor histocompatibility antigens

GPATCH1 GPATCH11 SON

1.12e-0422783579
GeneFamilyStructural maintenance of chromosomes proteins|Cohesin complex

SMC1A SMC1B

3.80e-047782761
GeneFamilyCohesin complex

SMC1A SMC1B

5.06e-0487821060
GeneFamilyDNA helicases

NCL RUVBL1

2.40e-03177821167
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

ARHGEF38 ARHGEF12 VAV3

2.91e-0366783722
GeneFamilyPolypeptide N-acetylgalactosaminyltransferases

GALNT18 GALNT5

3.32e-0320782433
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500

INSR EPB41L5 CEP350 SLC8A1 LNPEP VAV3 CUX1

1.21e-051631007gudmap_developingKidney_e15.5_cortic collect duct_500_k4
CoexpressionAtlasDevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500

OGFRL1 PRSS8 CNNM2 INSR EPB41L5 CEP350 CLIC5 LNPEP VAV3 CUX1

2.01e-0540210010gudmap_developingKidney_e15.5_anlage of loop of Henle_500
ToppCelldroplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP20A1 ZEB2 CEP350 SLC8A1 XIRP2 LNPEP VAV3

1.68e-071761027749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

USP34 NPR3 ARHGEF12 CEP350 CLIC5 KIF5B TNFSF15

2.44e-07186102703db813598b67b1e08f759758a1c2023396921fa
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

USP34 NPR3 RAPGEF5 ARHGEF12 GALNT18 SON NIN

3.99e-072001027dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 DOCK11 SYNE1 EPB41L5 CLIC5 MGAT4C

3.81e-0618110265f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 DOCK11 SYNE1 EPB41L5 CLIC5 MGAT4C

3.81e-061811026c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WAS RSF1 ZEB2 CEP350 VAV3 NIN

4.33e-0618510267adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCellE17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PRSS8 EPB41L5 GALNT18 CLIC5 TNFSF15 CUX1

5.04e-06190102615f314517ed47b12d287a12a7d18cb383310e25a
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM3 DOCK11 TRAC CLIC5 DNAJC9 TMPO

5.19e-061911026912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TPM3 DOCK11 TRAC CLIC5 DNAJC9 TMPO

5.19e-06191102677a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCellE12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HSPD1 NCL NUF2 DNAJC9 TMPO KPNA2

5.85e-06195102697b2ff072cc830a4a2cb217f5a215ca6cad505ec
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 EPB41L5 CLIC5 MAMDC2 MGAT4C

6.02e-06196102634e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 EPB41L5 CLIC5 MAMDC2 MGAT4C

6.02e-0619610268f82e01ca50aa4cd6149547505b4474a02fad618
ToppCellE12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

HSPD1 NCL NUF2 DNAJC9 TMPO KPNA2

6.02e-06196102662b2de1d38a99ab23211bf51595845f8a1fdb7d2
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

CDC42BPA INSR RSF1 CEP350 HSD17B12 KPNA2

6.38e-06198102676d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CDC42BPA INSR RSF1 CEP350 HSD17B12 ANKRD18A

6.57e-06199102661b1ed2db71b96157b92b7535d1955a4033098da
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

TPM3 RAPGEF5 TRPC4 ARHGEF12 NCL KIDINS220

6.57e-0619910261b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

CDC42BPA INSR RSF1 CEP350 HSD17B12 TNFSF15

6.57e-061991026c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

CDC42BPA INSR RSF1 OLFM4 UNC45A HSD17B12

6.57e-061991026d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

TPM3 RAPGEF5 TRPC4 ARHGEF12 NCL KIDINS220

6.57e-0619910264bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell(5)_Plasma-(5)_Plasmablast|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1)

HSPD1 PSMA7 NUF2 DNAJC9 TMPO KPNA2

6.76e-062001026bba54e9acc7514e123de083a4eb49e7bcdb3dac3
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAT2 ARHGEF38 EPB41L5 CLIC5 MTA3

4.02e-051661025c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OGFRL1 WAS MAGEC3 ZEB2 SLC8A1

4.76e-05172102572fbfa890995e47048b47199c170cc7dcd7661f8
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

OGFRL1 WAS MAGEC3 ZEB2 SLC8A1

4.76e-0517210252ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CDC42BPA ARHGEF12 SLC8A1 VAV3 MGAT4C

5.30e-0517610251dd54bfaa58541de51e5a8328651d390833bd480
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

NPR3 SYNE1 ZEB2 GFPT2 KPNA2

5.45e-05177102584930899eb2978598bc8a351cbcd9e714e46799d
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9

IFFO1 SYNE1 ZEB2 GFPT2 GALNT5

5.60e-051781025142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NPR3 CDC42BPA SLC10A4 OLFM4 ANKRD18A

5.90e-051801025f598bb9df0d784120847fada2d9a2a88b8b68cd1
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NPR3 CDC42BPA SLC10A4 OLFM4 ANKRD18A

5.90e-051801025b4fa047f271c7b56940bdc85c912f50aa5b5ca82
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DLG5 PTPRZ1 VAV3 MGAT4C CUX1

5.90e-051801025a407376209d80177bf7fc4200219030c83cb5f14
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CNNM2 CEL ABCA10 SLC8A1 VAV3

6.38e-0518310252f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPC4 ABCA10 ZEB2 SLC8A1 MGAT4C

6.55e-051841025e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPD1 NCL RUVBL1 TMPO TNFSF15

6.55e-051841025e7b9c69fc77040c5191ad8089697051e2589c30e
ToppCellPCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ZFP42 PRSS8 ARHGEF38 PTPRZ1 VAV3

6.55e-051841025fa4915b0498f3069fd5ef497286445528f75187e
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 EPB41L5 CLIC5 MGAT4C

6.72e-05185102534fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 EPB41L5 CLIC5 MGAT4C

6.72e-0518510258816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCelldroplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 GALNT18 CLIC5

7.07e-05187102552ffd4be374e329ac8d321063f061b826d252956
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor

RAPGEF5 GALNT18 PRKAR1B VAV3 MGAT4C

7.07e-0518710251e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRSS8 EPB41L5 CLIC5 GFPT2 GALNT5

7.25e-051881025e9cef856a96a97afac5ecafe2ee91eff0d731e01
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

NPR3 CDC42BPA SYNE1 INSR OLFM4

7.25e-051881025557a0ac069a6ff4e687cac032f64170b9b247165
ToppCelldroplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 ARHGEF12 GALNT18 CLIC5

7.43e-05189102525db316f66cee53774bb2b286cc457b37353356c
ToppCellE15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SMC1A NUF2 ZEB2 TMPO KPNA2

7.43e-051891025d049f33115610bda4489968759f754730698b9cd
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

ARHGEF12 SLC8A1 CLIC5 XIRP2 EXOC6B

7.43e-0518910250a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellCOVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK11 ZEB2 SLC8A1 MAMDC2 VAV3

7.43e-0518910252586f4088721c5debec86c2b211b739fd33713eb
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

ARHGEF12 SLC8A1 CLIC5 XIRP2 EXOC6B

7.62e-05190102593c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM3 ARHGEF12 NCL SON NIN

7.62e-051901025d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCelldroplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 SYNE1 ARHGEF12 GALNT18 CLIC5

7.62e-051901025e64b191f928935484e2c993d7f8af0572a617a3a
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM3 USP34 CEP350 KIF5B MGAT4C

7.81e-05191102560c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCellControl-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class

NPR3 RAPGEF5 SYNE1 ARHGEF12 GALNT18

7.81e-051911025c672c8e28d06d555335976b3f8bd2ea6d3b34aae
ToppCellControl-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class

NPR3 RAPGEF5 SYNE1 ARHGEF12 GALNT18

7.81e-051911025322237793a1278bafb14e63cab688b353e352dcc
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM3 USP34 CEP350 KIF5B MGAT4C

7.81e-05191102509db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPM3 USP34 CEP350 KIF5B MGAT4C

7.81e-051911025973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellfacs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 GALNT18 CLIC5

8.00e-051921025ba3fe97786564dba1c8185f2802ce1b57f4f3cc9
ToppCellfacs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 GALNT18 CLIC5

8.00e-05192102585d4d0df701451daf95e94a87a0096da1e86533b
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 ARHGEF12 GALNT18 CLIC5

8.00e-0519210254bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CDC42BPA URB2 SLC8A3 MAMDC2 KPNA2

8.00e-051921025d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCellfacs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 INSR CEP350

8.00e-0519210251ccc47792edf9ee23501c8e2165d11271636b66a
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

USP34 ARMC9 ZEB2 SLC8A1 CUX1

8.20e-051931025779276e775cb2492e8dd36436295a536084a6415
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 GALNT18 CLIC5

8.20e-0519310252218833749576ba1a0fc95bd155c781e7e1163c6
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

USP34 SMC1A RSF1 CEP350 SON

8.20e-051931025abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellPCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

NPR3 RAPGEF5 GALNT18 CLIC5 VAV3

8.20e-05193102572d20ee257149b238016b44d183ce3fc24b8f621
ToppCellfacs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 ARHGEF12 GALNT18 CLIC5

8.40e-051941025f159ef8541d75a4e98468947f231bb463bec922c
ToppCellfacs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 SYNE1 GALNT18 CLIC5

8.40e-051941025df56e23f1dcf1902d29392fcc947e0e268e1648b
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NPR3 COX16 NCL PTPRZ1 DNAJC9

8.40e-051941025ded64ddab86de17fcf8b70d31bc26796eb71d60f
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SMC1A TRAC NUF2 DNAJC9 TMPO

8.61e-05195102567670d16ddd5d5ab7bc2254df329f5a7b2581556
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SMC1A TRAC NUF2 DNAJC9 TMPO

8.61e-05195102523dc2f8a3a038195a31feee7e3a51094a7a7c23e
ToppCellfacs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NPR3 RAPGEF5 ARHGEF12 GALNT18 CLIC5

8.61e-0519510257f9b7f15006610ad591063d90e90367bd6083c7f
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

CDC42BPA RAPGEF5 SYNE1 ARHGEF12 GALNT18

8.82e-0519610254ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCellmyeloid-CD34+_Monoblast|myeloid / Lineage and Cell class

HSPD1 SMC1A NCL DNAJC9 TMPO

9.25e-051981025e26b98a8380e693110a97d8e5a353998f8d67c6d
ToppCellTCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

USP34 DOCK11 INSR SLC8A1 CLIC5

9.25e-051981025af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCellTCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9

USP34 DOCK11 INSR SLC8A1 CLIC5

9.25e-051981025ad39cce004867f083f8da1954e0cf5a263815184
ToppCell10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HSPD1 NPR3 CDC42BPA NCL DNAJC9

9.25e-051981025d5996bd3756fcd4d5866006da2ecd923f0f25427
ToppCellTCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9

USP34 DOCK11 INSR SLC8A1 CLIC5

9.25e-05198102562cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPD1 PRSS8 ARHGEF38 OLFM4 TNFSF15

9.47e-0519910257540973d36f78cd9f13210635ff0708d20c8b209
ToppCellILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TPM3 NUF2 DNAJC9 TMPO KPNA2

9.47e-051991025624a807fae0a080a4e6755dcb374c25b6f2d2cfe
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 CLIC5 MAMDC2 MGAT4C

9.47e-051991025b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCellHSPCs|World / Lineage and Cell class

HSPD1 NCL RUVBL1 DNAJC9 TMPO

9.47e-051991025df1ffc416c6946f1ba182f242a50ee41a571d565
ToppCell5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HSPD1 PRSS8 ARHGEF38 OLFM4 TNFSF15

9.47e-051991025416ea20b49a48bf47ec3abfbe707e4d1254e2f88
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

CDC42BPA RSF1 ARHGEF12 HSD17B12 TNFSF15

9.47e-05199102518a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Erythro-cells / Lineage, cell class and subclass

HSPD1 NUF2 DNAJC9 PRKAR1B TMPO

9.47e-051991025304681a6510c05203aab360ed72bfe929d8e4ac3
ToppCellControl-Control-Others-HSPC|Control / Disease, condition lineage and cell class

NPR3 CDC42BPA ZBTB8A SLC8A3 CCDC171

9.47e-051991025b71169be0d916b2ed139a3122d78bb154c71edb4
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

CDC42BPA INSR RSF1 CEP350 HSD17B12

9.47e-051991025fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellB_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class

SMC1A NUF2 DNAJC9 TMPO KPNA2

9.47e-0519910254bf6a656de04d92103cbe743cd07afd9d125c654
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NPR3 SYNE1 CLIC5 MAMDC2 MGAT4C

9.47e-051991025c972d3036151403f26fa9d6271520639c281ab84
ToppCellMS-Multiple_Sclerosis-Others-HSPC|Multiple_Sclerosis / Disease, condition lineage and cell class

NPR3 CDC42BPA CEL SLC8A3 XIRP2

9.47e-0519910257f4a22207a8b27af9a070d289e31ebd0e57af1a6
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CNNM2 DOCK11 SLC10A4 ZEB2 SLC8A1

9.69e-052001025b5b5a32925f225610fe25a021a742d6397162863
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

SMC1A NUF2 DNAJC9 TMPO KPNA2

9.69e-0520010255f2fbd789cc16af411a01c3199583888b260ae91
ToppCell(5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

HSPD1 NUF2 DNAJC9 TMPO KPNA2

9.69e-052001025948c55aa1c25f8a69b1bd3ef53fd32aa222f592c
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DOCK11 TRPC4 SLC10A4 ZEB2 SLC8A1

9.69e-052001025d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCellTransverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass

SMC1A NUF2 ZEB2 DNAJC9 TMPO

9.69e-052001025617a6a42f7b31eb3c45bdceaf55a591b6de7f154
ToppCell(5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

HSPD1 NUF2 DNAJC9 TMPO KPNA2

9.69e-052001025b46b2064362efc64edf19ab2b21bc89047c9d943
ToppCellBiopsy_Control_(H.)-Immune-Proliferating_Macrophages|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

NUF2 DNAJC9 TMPO SMC1B KPNA2

9.69e-052001025ce9fad55f779afd3d6c5a9c5a15e2d9f548b7c7e
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

CNNM2 DOCK11 SYNE1 ARMC9 SLC8A1

9.69e-052001025c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 NCL ZEB2 CEP350 SON

9.69e-05200102512f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ARHGEF12 GALNT18 KIDINS220 CLIC5

9.69e-052001025b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCellcritical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

NUF2 CEP350 TMPO CCDC171 KPNA2

9.69e-052001025f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC4 ABCA10 ZEB2 MAMDC2 GFPT2

9.69e-052001025cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SYNE1 ABCA10 ZEB2 SLC8A1 MAMDC2

9.69e-0520010253dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCellLPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

RAPGEF5 ARHGEF12 GALNT18 KIDINS220 CLIC5

9.69e-052001025b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

RAPGEF5 ARHGEF12 GALNT18 KIDINS220 CLIC5

9.69e-05200102558a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCellControl_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type

CNNM2 DOCK11 SLC10A4 ZEB2 SLC8A1

9.69e-052001025cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
DrugAC1MNCFH

SYNE1 INSR CUX1

3.02e-0671023CID003301780
Drugphenylpropionic acid

HSPD1 NAT1 NAT2 TNFAIP8L3 MAGEC3 CLIC5 MAGEC2

1.04e-051671027CID000000107
Drugmethyl triflate

SYNE1 INSR MGAT4C

1.86e-05121023CID000009526
Drug4-iodoaniline

NAT1 NAT2

1.99e-0521022ctd:C013067
DrugN-hydroxy-2-aminofluorene

NAT1 NAT2

1.99e-0521022ctd:C001368
Drug4-bromoaniline

NAT1 NAT2

1.99e-0521022ctd:C023621
Drugbromoacetanilide

NAT1 NAT2

1.99e-0521022ctd:C056005
Drug2-(bromoacetylamino)fluorene

NAT1 NAT2

1.99e-0521022ctd:C075748
Drugaspartimide

NAT1 NAT2 INSR

3.07e-05141023CID000188987
DrugN-hydroxy-4-acetylaminobiphenyl

NAT1 NAT2

5.94e-0531022ctd:C001365
Drug10-propargylaminopterin

SYNE1 DHFR2

5.94e-0531022CID000100093
Drug3,5-dimethylaniline

NAT1 NAT2

5.94e-0531022CID000007949
DrugAminosalicylic Acid

NAT1 NAT2

5.94e-0531022ctd:D010131
DrugI 324

NAT1 NAT2

5.94e-0531022CID000031230
Drugmethyluracil

NAT2 TMPO

5.94e-0531022CID000079066
DrugHair Dyes

NAT1 NAT2

5.94e-0531022ctd:D006202
DrugGlu-asp-gly

NAT1 NAT2

5.94e-0531022CID000194641
Drug3-ethylaniline

NAT1 NAT2

5.94e-0531022CID000011475
Diseaseoccupational dermatitis (is_implicated_in)

NAT1 NAT2

1.16e-0521012DOID:4404 (is_implicated_in)
Diseaselevel of prefoldin subunit 3 in blood serum

PSMA7 C6

3.47e-0531012OBA_2044087
Diseaseurate measurement, bone density

NAT1 WDR64 SYNE1 GALNT18 FSIP2 KIDINS220 MRPS23 PRKAR1B HSD17B12 GFPT2

5.32e-0561910110EFO_0003923, EFO_0004531
Diseaseallergic contact dermatitis (is_implicated_in)

NAT1 NAT2

1.72e-0461012DOID:3042 (is_implicated_in)
DiseaseCD97 antigen measurement

PSMA7 C6

1.72e-0461012EFO_0020250
Diseasecarbonic anhydrase 4 measurement

PSMA7 C6

1.72e-0461012EFO_0020230
Diseasecalcineurin subunit B type 1 measurement

PSMA7 C6

2.41e-0471012EFO_0020215
DiseaseIndustrial Dermatosis

NAT1 NAT2

3.20e-0481012C0086457
DiseaseDermatitis, Occupational

NAT1 NAT2

3.20e-0481012C0028796
Diseaseinfection

RSF1 ZNF541

4.11e-0491012EFO_0000544
Diseaseapolipoprotein D measurement

PSMA7 C6

4.11e-0491012EFO_0020156
Diseasekallikrein-14 measurement

PSMA7 C6

4.11e-0491012EFO_0020513
Disease5-acetylamino-6-formylamino-3-methyluracil measurement

NAT1 NAT2

4.11e-0491012EFO_0800950
Diseasetropomyosin beta chain measurement

PSMA7 C6

5.13e-04101012EFO_0020787
Diseasetumor necrosis factor receptor superfamily member 11B measurement

PSMA7 C6

6.25e-04111012EFO_0020801
Diseaseserum IgG measurement, response to dietary antigen

ARMC9 KCNK10

6.25e-04111012EFO_0004565, EFO_0005844
Disease5-acetylamino-6-amino-3-methyluracil measurement

NAT1 NAT2

6.25e-04111012EFO_0800951
Diseasecomplement component C7 measurement

PSMA7 C6

7.49e-04121012EFO_0008093
DiseaseADHD symptom measurement

ARHGEF12 CUX1

7.49e-04121012EFO_0007860
DiseaseN-acetylputrescine measurement

NAT1 NAT2

7.49e-04121012EFO_0800127
Diseasetyrosine-protein kinase ZAP-70 measurement

PSMA7 C6

7.49e-04121012EFO_0020833
DiseaseAutosomal Dominant Myotubular Myopathy

TPM3 MTMR14

8.83e-04131012C3661489
DiseaseCentronuclear myopathy

TPM3 MTMR14

8.83e-04131012C0175709
DiseaseX-linked centronuclear myopathy

TPM3 MTMR14

8.83e-04131012C0410203
Diseasecomplement component C6 measurement

PSMA7 C6

8.83e-04131012EFO_0020281
DiseaseCongenital Structural Myopathy

TPM3 MTMR14

8.83e-04131012C0752282
DiseaseMyopathy, Centronuclear, 1

TPM3 MTMR14

8.83e-04131012C4551952
DiseaseMyopathy, Centronuclear, Autosomal Dominant

TPM3 MTMR14

1.03e-03141012C1834558
DiseaseTubular Aggregate Myopathy

TPM3 MTMR14

1.03e-03141012C0410207
DiseaseMalignant neoplasm of breast

NAT2 SYNE1 TRPC4 ARHGEF38 ZEB2 SLC8A3 MRPS23 GALNT5 MAGEC2 CUX1 ZNF541

1.13e-03107410111C0006142
DiseaseAutosomal Recessive Centronuclear Myopathy

TPM3 MTMR14

1.18e-03151012C3645536
DiseaseBladder Neoplasm

NAT1 NAT2 SMC1A SMC1B

1.39e-031401014C0005695
DiseaseMalignant neoplasm of urinary bladder

NAT1 NAT2 SMC1A SMC1B

1.42e-031411014C0005684
DiseaseMalignant neoplasm of endometrium

PMS1 CUX1

1.71e-03181012C0007103
DiseaseCongenital Fiber Type Disproportion

TPM3 MTMR14

1.71e-03181012C0546264
DiseaseCarcinoma in situ of endometrium

PMS1 CUX1

1.71e-03181012C0346191

Protein segments in the cluster

PeptideGeneStartEntry
SDISLVDYTKEDKTF

TNFSF15

231

O95150
DEEAYITLEKISKAF

URB2

781

Q14146
YKDNTDLIEFKTLSE

NAT1

246

P18440
KTAYEEVTTELEEFK

ANKRD18A

881

Q8IVF6
DAKLTTESEEKLVYS

ABCA10

646

Q8WWZ4
LFDLKTKYDEETTAK

CUX1

211

P39880
SILESYEKEEELKEH

ARHGEF38

196

Q9NXL2
LKAELDTTYTFLKET

CCDC171

1281

Q6TFL3
EQLDVTTSEYEKEKL

HSPD1

376

P10809
ISLESEYEKIKDSKF

COX16

61

Q9P0S2
EEDFYKLVSEFTITK

CEL

361

P19835
FKLVSEAYEVLSDSK

DNAJB8

46

Q8NHS0
KIEEFLEETLTPEKY

CLIC5

246

Q9NZA1
RKYSIFTEKDEILSD

ATG4B

31

Q9Y4P1
EADLEHLKKVEESYT

ARHGEF12

1511

Q9NZN5
TSIYSFDETKDLDLE

NPR3

231

P17342
SQEVEDKTKEYELLS

KIF5B

506

P33176
LLSVYLKKEEDSEES

MAMDC2

596

Q7Z304
LDEDEDTDISYKKLK

SLC10A4

396

Q96EP9
KSIFEQSSYEELKEI

MGAT4C

121

Q9UBM8
LTTYEIEEFKKTKEA

OGFRL1

176

Q5TC84
EYLSDALLDKKDSSD

KIDINS220

1571

Q9ULH0
TDDFKSKYESELSLR

KRT40

171

Q6A162
ELDTDEYEETKKETL

LZIC

36

Q8WZA0
EYEETKKETLEQLSE

LZIC

41

Q8WZA0
SFTYTLDEKVAELVE

MAGEC2

136

Q9UBF1
SEPLFTYTLDEKVDK

MAGEC3

176

Q8TD91
FLEYESSEKEKDTFE

MTMR14

91

Q8NCE2
ELTEFYEAKLQEKTT

CFAP57

826

Q96MR6
KEYLDFAEFEDTLKT

ARMC9

16

Q7Z3E5
DSYELSTDLQDKKVE

IQSEC2

321

Q5JU85
ELFDLKTKYDEETTA

CUX1

221

Q13948
EIRFSKEEEETKFIY

FSIP2

4521

Q5CZC0
TETLSKYDTVLKDEE

GPATCH1

301

Q9BRR8
AEDSYAKIDEKTAEL

NUF2

441

Q9BZD4
ELSFKKDDILYVDDT

DLG5

1611

Q8TDM6
FSLEKIFKELSSYED

LNPEP

496

Q9UIQ6
FRNYSLDEEKKEEET

KCNK10

476

P57789
DRYSDNEEDSKIELK

TMPO

181

P42167
SKKDAYIIFDTEIES

EXOC6B

246

Q9Y2D4
KELEESSFRKTFEDY

INSR

721

P06213
TEYEEESLLTSFKLD

PTPRZ1

566

P23471
FDYLTEKVALSEKET

PHKG2

116

P15735
IAYIEFKTEADAEKT

NCL

431

P19338
YSITAEDLDLEKKAS

POM121C

506

A8CG34
DTESLFKTREKEYQE

IFFO1

461

Q0D2I5
KASLSLIEKYFSVEE

KPNA2

486

P52292
EVEYETLKDTSEKLK

EPB41L5

496

Q9HCM4
EDEYKSEDLSVLEKL

GPATCH11

231

Q8N954
YFDDKELTERKTEFE

DOCK11

1841

Q5JSL3
ESETDTETIAKLIKY

GFPT2

141

O94808
AEDDLKTDFYKDLTS

C6

246

P13671
ILLVDDFSTKDYLKD

GALNT5

531

Q7Z7M9
SSNEELKEKLTEYVD

GALNT18

196

Q6P9A2
SYDEFIKKTEAELSQ

CEP350

2096

Q5VT06
KEISAELYKDDFEVS

CEP350

2386

Q5VT06
AVDFASEDIYDKIKT

HSD17B12

106

Q53GQ0
FEKTYKGSEEELADI

DNAJC9

116

Q8WXX5
LELLAEEESYFSTVK

GHRHR

116

Q02643
YKDNTDLVEFKTLTE

NAT2

246

P11245
DTFFSEIDLEKYKLL

DHFR2

146

Q86XF0
YEEFLSKVSILESLD

PRKAR1A

246

P10644
YEEFLSKVSILESLE

PRKAR1B

246

P31321
FLTTSEEVQKKLYEE

CYP20A1

291

Q6UW02
TEEYSEKFSEDAKSI

GRK4

406

P32298
ESYLSKNSEDDELAK

RSF1

1251

Q96T23
TEDLYSIFTKEKEHE

INPP5F

571

Q9Y2H2
TLSEEEKLKYEEKAT

PMS1

611

P54277
ELFDYLTEKVTLSEK

PHKG1

111

Q16816
ETESVLSYLDKEDTF

MTA3

116

Q9BTC8
EKYTELQKLGETDEE

MRPS23

101

Q9Y3D9
KKDDFVLDSEYLVTL

ATP6V1C1

171

P21283
KSRELYEKTEDESFK

SYNE1

2796

Q8NF91
VLDYETFAKSLEALE

SYNE1

7351

Q8NF91
TETFLSLEKSYDEVK

NIN

1301

Q8N4C6
KETETLLDDFLLTYT

RAPGEF5

96

Q92565
DSYSEDAKVSTLKDI

PRSS8

106

Q16651
TDLEKKSIFYEEELS

CDC42BPA

691

Q5VT25
KDTISYTELDFELIK

OLFM4

146

Q6UX06
SKDSDVYITDKTVLD

TRAC

36

P01848
IIKSEILDETDLYTD

CNNM2

576

Q9H8M5
EEFSLFKVSDDEYKV

CNNM3

476

Q8NE01
LLKTIEEFYKSEDGE

RNF17

706

Q9BXT8
TFSLDEIKEESDYIS

XIRP2

1106

A4UGR9
LIDDTSSEIFDELYK

TNFAIP8L3

136

Q5GJ75
SSEIFDELYKVTKEH

TNFAIP8L3

141

Q5GJ75
SLDISEKEKDRYFSL

ZBTB8A

121

Q96BR9
LTKEETHTIKLEDSY

ZNF287

256

Q9HBT7
KEEAFEIDYSSLKED

SMC1B

971

Q8NDV3
SKDSDVYITDKTVLD

TRA

171

P0DTU3
LTDAETSKLIYDFIE

WAS

281

P42768
VISLKEEFYTKAESL

SMC1A

1186

Q14683
EEISELFYDAKSSAK

RUVBL1

431

Q9Y265
LEEDSLFESLEYLKK

ZFP42

86

Q96MM3
KAEALIKLSDYDSSE

TTC37

356

Q6PGP7
IYESLDEVTIKDTLE

USP34

2041

Q70CQ2
TSDFEEYFAKRKLEE

ZEB2

141

O60315
LKYGAFEVTEDTEKL

WDR11

1161

Q9BZH6
YTDEAIETDDLTIKL

PSMA7

176

O14818
ESSSEEKDDYEIFVK

SON

1781

P18583
LKGTEDELDKYSEAL

TPM3

51

P06753
LEDYDKAETEASKAI

UNC45A

71

Q9H3U1
SKVENEFKSEYEELS

TRPC4

231

Q9UBN4
KDSDSVKLLEEYADS

ZNF541

81

Q9H0D2
TEYPIEIKEESKFTE

WDR64

926

B1ANS9
KQTEEKYTETLESIE

VAV3

201

Q9UKW4
IEESYEFKSTVDKLI

SLC8A1

716

P32418
EESYEFKTTVDKLIK

SLC8A3

671

P57103